Replies to post #5913 on InVivo Therapeutics Holdings Corp (NVIVQ)

[Pemmanuel]

I don't know what there is to be concerned about. Companies do this all the time. If they dilute 10% of their shares but the share price rises 500% on FDA approval who cares. The company has almost a year of cash and they can do a raise months from now after they have all 20 patients and additional positive results rolling in. NVIV used to raise money with less in the bank and nobody ever cared when they were still on the drawing board. Now they are close. People need to chill and not make this an issue because it really isn't.